Atria Wealth Solutions Inc. Has $16.96 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Key Points

• Atria Wealth Solutions Inc. reduced its holdings in UnitedHealth Group by 9.5%, owning 32,375 shares valued at approximately $16.96 million as of its latest SEC filing.
• Major institutional investors made significant changes to their positions in UnitedHealth Group in the last quarter, with some, like UBS AM, increasing their stake by 36.6%.
• UnitedHealth Group recently increased its quarterly dividend to $2.21 per share, reflecting a boost from the previous $2.10, and representing an annualized payout of $8.84 with a yield of 3.7%.

Atria Wealth Solutions Inc. lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 32,375 shares of the healthcare conglomerate's stock after selling 3,416 shares during the quarter. Atria Wealth Solutions Inc.'s holdings in UnitedHealth Group were worth $16,956,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Capital International Investors lifted its stake in UnitedHealth Group by 6.2% during the 4th quarter. Capital International Investors now owns 15,616,007 shares of the healthcare conglomerate's stock valued at $7,899,905,000 after acquiring an additional 906,365 shares in the last quarter. Northern Trust Corp raised its holdings in shares of UnitedHealth Group by 12.5% in the fourth quarter. Northern Trust Corp now owns 9,503,671 shares of the healthcare conglomerate's stock valued at $4,807,527,000 after purchasing an additional 1,058,488 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. GAMMA Investing LLC increased its stake in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its position in shares of UnitedHealth Group by 2.5% during the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock worth $4,257,131,000 after buying an additional 196,696 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on UNH shares. Raymond James Financial lowered UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Truist Financial lowered their target price on UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research note on Wednesday, July 16th. UBS Group restated a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Robert W. Baird reiterated an "underperform" rating and issued a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, Piper Sandler lowered their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Three equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Hold" and an average price target of $371.67.

Insider Activity

In other news, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction on Friday, May 16th. The stock was acquired at an average price of $291.12 per share, with a total value of $4,999,986.00. Following the completion of the purchase, the chief financial officer directly owned 203,796 shares in the company, valued at $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer directly owned 10,398 shares of the company's stock, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Stock Up 1.3%

UNH opened at $240.94 on Tuesday. The firm has a market capitalization of $218.57 billion, a P/E ratio of 10.44, a price-to-earnings-growth ratio of 1.50 and a beta of 0.43. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The company has a fifty day moving average price of $295.77 and a 200-day moving average price of $412.81. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The company had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the company posted $6.80 earnings per share. The firm's revenue for the quarter was up 12.9% on a year-over-year basis. Equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a dividend of $2.21 per share. This is a boost from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date was Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 3.7%. UnitedHealth Group's dividend payout ratio is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.